Secondary outcomes include leukemia-free survival, quality of life, and cost-effectiveness.
Apart from survival, quality of life (QOL) targeting on dealing with functional and aesthetic impairments became more important in the last 15 years.
Kidney transplantation represents the best therapeutic option for patients with end-stage renal disease (ESRD), providing the best outcomes for survival, quality of life, and cost-effectiveness.
The secondary objectives are to determine the effect of dose escalation on overall survival, progression free survival, quality of life and rate of grade 3-5 toxicities.
We chose to define patient-important outcomes according to these patients' priorities (survival, quality of life, functional, cognitive and neurological performance assessed after ICU discharge) as it has been done in other fields such as diabetes [13].
Methods and Results The Mediators of Social Support Study (MOSS) prospectively followed up outcomes of long-term survival, quality of life, resource use, and costs for 1189 patients and compared outcomes of patients with advanced coronary artery disease with those of a reference group who underwent bypass surgery or angioplasty.
For a more comprehensive determination of cost-effectiveness from the societal perspective, more data is needed on the value of averted infections in terms of the additional survival, quality of life and the costs of MRSA infection, during hospital stay as well as after discharge.
Research about survival quality has received increasing attention in the international community in recent years.
Secondary end points include: survival, quality of life, performance status and neurocognitive function.
Secondary endpoints included duration of response, time to progression, survival, quality of life, and safety.
Secondary outcomes include overall and disease free survival, quality of mesorectal excision, rate of sphincter preservation.
